• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病的小鼠模型

Mouse models of inflammatory bowel disease.

作者信息

Wirtz Stefan, Neurath Markus F

机构信息

Laboratory of Immunology, I. Medical Clinic, University of Mainz, Obere Zahlbacher Strasse 63, 55131 Mainz, Germany.

出版信息

Adv Drug Deliv Rev. 2007 Sep 30;59(11):1073-83. doi: 10.1016/j.addr.2007.07.003. Epub 2007 Aug 16.

DOI:10.1016/j.addr.2007.07.003
PMID:17825455
Abstract

Animal models of intestinal inflammation are indispensable for our understanding of the pathogenesis of Crohn disease and Ulcerative colitis, the idiopathic forms of inflammatory bowel disease in humans. The clinical appearance of human IBD is heterogeneous, a fact that is also reflected by the steadily increasing number of mouse strains displaying IBD like intestinal alterations. The analysis of these models together with genetic studies in humans greatly enhanced our insights into immunoregulatory processes in the gut and led to the generally accepted hypothesis that a deregulated immune response against components of the intestinal microbiota is critically involved in IBD pathophysiology. In this article we provide a brief overview of selected mouse models of IBD and discuss their contribution to the current understanding of disease mechanisms that contribute to IBD.

摘要

肠道炎症的动物模型对于我们理解克罗恩病和溃疡性结肠炎(人类特发性炎症性肠病的两种形式)的发病机制不可或缺。人类炎症性肠病的临床表现具有异质性,这一事实也体现在表现出类似炎症性肠病肠道改变的小鼠品系数量不断增加上。对这些模型的分析以及人类遗传学研究极大地增进了我们对肠道免疫调节过程的认识,并得出了一个被广泛接受的假说,即针对肠道微生物群成分的免疫反应失调在炎症性肠病的病理生理学中起着关键作用。在本文中,我们简要概述了选定的炎症性肠病小鼠模型,并讨论它们对当前对导致炎症性肠病的疾病机制理解的贡献。

相似文献

1
Mouse models of inflammatory bowel disease.炎症性肠病的小鼠模型
Adv Drug Deliv Rev. 2007 Sep 30;59(11):1073-83. doi: 10.1016/j.addr.2007.07.003. Epub 2007 Aug 16.
2
Involvement of innate immunity in the development of inflammatory and autoimmune diseases.固有免疫在炎症性疾病和自身免疫性疾病发展中的作用。
Ann N Y Acad Sci. 2005 Jun;1051:787-98. doi: 10.1196/annals.1361.122.
3
[Inflammatory bowel disease: IBD].[炎症性肠病:IBD]
Rinsho Byori. 2009 Jun;57(6):527-32.
4
Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota.炎症性肠病的实验模型揭示了宿主与微生物群对话的固有、适应性和调节机制。
Immunol Rev. 2005 Aug;206:260-76. doi: 10.1111/j.0105-2896.2005.00291.x.
5
NF-kappaB in inflammatory bowel disease.炎症性肠病中的核因子κB
J Intern Med. 2008 Jun;263(6):591-6. doi: 10.1111/j.1365-2796.2008.01953.x.
6
Experimental models of inflammatory bowel disease.炎症性肠病的实验模型
Arch Immunol Ther Exp (Warsz). 2003;51(3):149-55.
7
Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy.炎症性肠病:发病机制和治疗的既定和不断发展的考虑因素。
J Dig Dis. 2010 Oct;11(5):266-76. doi: 10.1111/j.1751-2980.2010.00449.x.
8
The immune response in inflammatory bowel disease.炎症性肠病中的免疫反应。
Am J Gastroenterol. 2007 Sep;102(9):2058-69. doi: 10.1111/j.1572-0241.2007.01343.x. Epub 2007 Jun 11.
9
Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease.肠道炎症小鼠模型作为理解炎症性肠病发病机制的工具。
Eur J Immunol. 2009 Aug;39(8):2021-6. doi: 10.1002/eji.200939602.
10
Inflammatory bowel disease: a model of chronic inflammation-induced cancer.炎症性肠病:慢性炎症诱发癌症的模型。
Methods Mol Biol. 2009;511:193-233. doi: 10.1007/978-1-59745-447-6_9.

引用本文的文献

1
DCLK1 isoform (DCLK1-S) as a critical player in promoting inflammation, tissue remodeling, and EMT in mouse models of colitis.DCLK1 异构体(DCLK1-S)在促进结肠炎小鼠模型中的炎症、组织重塑和上皮-间质转化过程中起关键作用。
PLoS Pathog. 2025 Aug 21;21(8):e1013360. doi: 10.1371/journal.ppat.1013360. eCollection 2025 Aug.
2
Protective and therapeutic potentials of Trichinella spiralis larval antigen in murine induced colitis.旋毛虫幼虫抗原在小鼠诱导性结肠炎中的保护和治疗潜力
Sci Rep. 2025 Aug 19;15(1):30319. doi: 10.1038/s41598-025-13229-3.
3
Anti-Inflammatory Effects of Extract on Dextran Sodium Sulfate-Induced Colitis in Mice.
提取物对葡聚糖硫酸钠诱导的小鼠结肠炎的抗炎作用。
Curr Issues Mol Biol. 2025 May 23;47(6):389. doi: 10.3390/cimb47060389.
4
Exopolysaccharide of Levilactobacillus brevis M-10 Improved Physiological and Biochemical Indicators and Gut Microbiota in DSS-Induced Colitis Mice.短乳杆菌M-10的胞外多糖改善了葡聚糖硫酸钠诱导的结肠炎小鼠的生理生化指标和肠道微生物群
Curr Microbiol. 2025 Mar 24;82(5):204. doi: 10.1007/s00284-025-04190-5.
5
Mannose coated selenium nanoparticles normalize intestinal homeostasis in mice and mitigate colitis by inhibiting NF-κB activation and enhancing glutathione peroxidase expression.甘露糖修饰的硒纳米颗粒通过抑制 NF-κB 激活和增强谷胱甘肽过氧化物酶表达,使小鼠的肠道内稳态正常化,并减轻结肠炎。
J Nanobiotechnology. 2024 Oct 10;22(1):613. doi: 10.1186/s12951-024-02861-2.
6
Fecal let-7b and miR-21 directly modulate the intestinal microbiota, driving chronic inflammation.粪便 let-7b 和 miR-21 直接调节肠道微生物群,从而引发慢性炎症。
Gut Microbes. 2024 Jan-Dec;16(1):2394249. doi: 10.1080/19490976.2024.2394249. Epub 2024 Sep 3.
7
Establishment and Evaluation of a Mouse Model of Experimental Ulcerative Colitis Induced by the Gavage Administration of Dextran Sulfate Sodium.通过灌胃给予葡聚糖硫酸钠诱导的实验性溃疡性结肠炎小鼠模型的建立与评价
Biomedicines. 2024 Aug 5;12(8):1764. doi: 10.3390/biomedicines12081764.
8
The Impact of the CB Cannabinoid Receptor in Inflammatory Diseases: An Update.CB 大麻素受体在炎症性疾病中的作用:最新研究进展。
Molecules. 2024 Jul 18;29(14):3381. doi: 10.3390/molecules29143381.
9
High Cannabigerol Hemp Extract Moderates Colitis and Modulates the Microbiome in an Inflammatory Bowel Disease Model.高大麻萜酚大麻素提取物可缓解结肠炎并调节炎症性肠病模型中的微生物组。
J Pharmacol Exp Ther. 2024 Aug 19;390(3):331-341. doi: 10.1124/jpet.124.002204.
10
Early Growth Response Protein 1 Exacerbates Murine Inflammatory Bowel Disease by Transcriptional Activation of Matrix Metalloproteinase 12.早期生长反应蛋白1通过转录激活基质金属蛋白酶12加重小鼠炎症性肠病。
Biomedicines. 2024 Apr 2;12(4):780. doi: 10.3390/biomedicines12040780.